What does it take for a country to develop and build a truly innovative pharmaceutical sector, especially when it comes to emerging markets? Although there has been tremendous overall economic growth in recent decades, why is there yet no world-class innovation hub in these geographies? And how is it that some places in the world are able to foster innovation, while others fail in spite of strong efforts? Are there certain key elements that are critical? In Drugs, Politics, and Innovation, author Ajay Gautam presents a new paradigm for understanding the healthcare ecosystems in markets and in countries likely to emerge as future innovation leaders. Using case studies and the author's own experiences from various emerging markets such as China, India, Russia, Brazil, Egypt, Saudi Arabia, the Uae, Mexico, as well as Israel and the United States, it evaluates and contrasts the approaches key countries are taking, and it forecasts what the future may hold for such efforts with respect to the life sciences, biotech, and pharmaceutical industries. Using the Vital model-built on critical elements like venture capital and funding, research and design infrastructure, a talent pool, leading universities and academia, and government policies, incentives, and legislation-can help provide a framework for creating a sustainable, optimal, and productive innovation ecosystem.
"synopsis" may belong to another edition of this title.
Dr. Ajay Gautam has spent the last decade as a scientist and industry practitioner in healthcare strategy, living and working across Asia Pacific, Latin America, Middle East–Africa, Russia, and the United States. His view of innovation ecosystems stems from his experiences with local entrepreneurs, biotechs, and government and research institutions.
"About this title" may belong to another edition of this title.
Seller: Chiron Media, Wallingford, United Kingdom
PF. Condition: New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Seller Inventory # 6666-IUK-9781482864151
Quantity: 20 available
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Paperback. Condition: New. Seller Inventory # LU-9781482864151
Quantity: Over 20 available
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9781482864151
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In English. Seller Inventory # ria9781482864151_new
Quantity: Over 20 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Seller Inventory # C9781482864151
Quantity: Over 20 available
Seller: Books Puddle, Woodside, NY, U.S.A.
Condition: New. Seller Inventory # 26376415322
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Seller Inventory # 370678661
Quantity: 1 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND. Seller Inventory # 18376415312
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - What does it take for a country to develop and build a truly innovative pharmaceutical sector, especially when it comes to emerging markets Although there has been tremendous overall economic growth in recent decades, why is there yet no world-class innovation hub in these geographies And how is it that some places in the world are able to foster innovation, while others fail in spite of strong efforts Are there certain key elements that are critical In Drugs, Politics, and Innovation, author Ajay Gautam presents a new paradigm for understanding the healthcare ecosystems in markets and in countries likely to emerge as future innovation leaders. Using case studies and the author's own experiences from various emerging markets such as China, India, Russia, Brazil, Egypt, Saudi Arabia, the UAE, Mexico, as well as Israel and the United States, it evaluates and contrasts the approaches key countries are taking, and it forecasts what the future may hold for such efforts with respect to the life sciences, biotech, and pharmaceutical industries. Using the VITAL model-built on critical elements like venture capital and funding, research and design infrastructure, a talent pool, leading universities and academia, and government policies, incentives, and legislation-can help provide a framework for creating a sustainable, optimal, and productive innovation ecosystem. Seller Inventory # 9781482864151
Seller: moluna, Greven, Germany
Kartoniert / Broschiert. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. KlappentextrnrnWhat does it take for a country to develop and build a truly innovative pharmaceutical sector, especially when it comes to emerging markets? Although there has been tremendous overall economic growth in recent decades, why is ther. Seller Inventory # 447914340
Quantity: Over 20 available